Michael R. Prow - Concepedia

Author

Michael R. Prow

Vertex Pharmaceuticals (United Kingdom)

Also Known As

Michael Prow, Michael R. Prow

Publications

353

Citations

H-Index

Concepts

All Affiliations

Vertex Pharmaceuticals (United Kingdom)Critical Pharmaceuticals (United Kingdom)Walgreens Boots Alliance (United Kingdom)University of Nottingham

About

Michael R. Prow is an author at Vertex Pharmaceuticals (United Kingdom) specializing in medicine, neuropharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	209
2	Social Sciences	3	3	117
3	Neurology	2	2	101
4	Health Sciences	1	1	36
5	Immunology	1	1	26

Michael R. Prow

Publications

353

Citations

H-Index

Page 1

	Year	Citations
Characterization of 8‐OH‐DPAT‐induced hypothermia in mice as a 5‐HT<sub>1A</sub> autoreceptor response and its evaluation as a model to selectively identify antidepressants Keith F. Martin, Ian Phillips, Mitchell Hearson, British Journal of Pharmacology	1992	117
Quantification of presynaptic α2-adrenoceptors in rat brain after short-term DSP-4 lesioning David J. Heal, Sarah Butler, Michael R. Prow, European Journal of Pharmacology Synaptic TransmissionShort-term Dsp-4 LesioningSynaptic SignalingSocial SciencesRat Brain	1993	71
Clonidine-induced hypoactivity and mydriasis in mice are respectively mediated via pre- and postsynaptic α2-adrenoceptors in the brain David J. Heal, Michael R. Prow, W. R. Buckett European Journal of Pharmacology NeurophysiologyMedicineSynaptic TransmissionPhysiologyNeuroendocrine Mechanism	1989	36
Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic α2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride David J. Heal, Michael R. Prow, W. R. Buckett Psychopharmacology Antidepressant DrugsSibutramine HydrochloridePsychiatryNeurophysiologyPsychotropic Medication	1991	30
Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats – possible relevance in the psychopathology and treatment of binge-eating disorder David J. Heal, Michelle Hallam, Michael R. Prow, Journal of Psychopharmacology	2017	27
8-OH-DPAT-induced mydriasis in mice: A pharmacological characterisation Michael R. Prow, Keith F. Martin, David J. Heal European Journal of Pharmacology Autoimmune DiseaseDisease MechanismImmunologyExperimental PharmacologyPharmacotherapy	1996	26
Receptor binding and functional evidence suggest that postsynaptic α2-adrenoceptors in rat brain are of the α2D subtype David J. Heal, Sharon C. Cheetham, Sarah Butler, European Journal of Pharmacology Synaptic PlasticityNeurophysiologySynaptic TransmissionPhysiologyNeurotransmitter Receptors	1995	16
Clonidine produces mydriasis in conscious mice by activating central α2-adrenoceptors David J. Heal, Michael R. Prow, W. R. Buckett European Journal of Pharmacology Conscious MiceMedicinePhysiologyNeuropharmacologyPharmacology	1989	16
A comparison of various antidepressant drugs demonstrates rapid desensitisation of α2-adrenoceptors exclusively by sibutramine hydrochloride David J. Heal, Michael R. Prow, Jane Gosden, Psychopharmacology Molecular PharmacologySibutramine HydrochloridePsychiatryMedicinePsychotropic Medication	1992	14

Page 1